Ryan Feldman, PharmD, BCPS, DABAT

Clinical Assistant Professor, Department of Clinical Sciences

Contact Information

rfeldman@mcw.edu

Education

Post Graduate Year Two (PGY-2) Emergency Medicine Residency- Froedtert Hospital
Post Graduate Year One (PGY-1) Pharmacy Practice Residency- Froedtert Hospital
Doctor of Pharmacy- University of Wisconsin Madison School of Pharmacy- Madison, WI
Pre-pharmacy course work- University of Wisconsin Milwaukee- Milwaukee, WI

Diplomate of the American Board of Applied Toxicology (DABAT)
Board Certified Pharmacotherapy Specialist (BCPS)
American Heart Association Pediatric Advanced Life Support (PALS)
Basic Disaster Life Support (BDLS)
Teaching Certificate- Concordia University of Wisconsin
American Heart Association Advanced Cardiovascular Life Support (ACLS)
American Pharmacist Association Pharmacy Based Immunization Delivery
American Heart Association Basic Life Support (BLS)

Biography

Dr. Ryan Feldman joined the Medical College of Wisconsin School of Pharmacy in July 2019. He completed his Doctor of Pharmacy at the University of Wisconsin-Madison and continued on to complete two years of residency training with his second year focusing in emergency medicine and toxicology. After residency, Dr. Feldman began work as an Emergency Medicine Clinical Pharmacist at a level one trauma and academic medical center. He also maintained an appointment at the Wisconsin Poison Center as a Certified Poison Specialist, triaging and providing medical recommendations for poisoned patients throughout Wisconsin. In October 2018, he became credentialed as a Board Certified Clinical Toxicologist through the American Board of Applied Toxicology (ABAT). He now works as a consulting clinical toxicologist and acts as the co-chair for the Acute & Intensive Care Section of the American Academy of Clinical Toxicology. Dr. Feldman’s current activities include full time clinical work as an Emergency Medicine Clinical Pharmacist and Toxicologist, pursuing clinical research, precepting pharmacy learners, and acting as a core preceptor for the Emergency Medicine Pharmacy Residency at Froedtert Hospital.

Research Interests

Resuscitation
Infectious disease
Toxicology
Poisoning epidemiology
Comparative clinical outcomes research

Compiling Evidence for EVALI: A Scoping Review of In Vivo Pulmonary Effects After Inhaling Vitamin E or Vitamin E Acetate.

(Feldman R, Stanton M, Suelzer EM.) J Med Toxicol. 2021 07;17(3):278-288 PMID: 33528766 PMCID: PMC8206445 SCOPUS ID: 2-s2.0-85100353209 02/03/2021
Comparison of Clinical Outcomes with Initial Norepinephrine or Epinephrine for Hemodynamic Support After Return of Spontaneous Circulation.

(Weiss A, Dang C, Mabrey D, Stanton M, Feih J, Rein L, Feldman R.) Shock. 2021 Jun 24 PMID: 34172611 06/27/2021
Choosing a Vasopressor for a Prehospital Emergency Medical System: Consideration for Agent Selection and Review of Pharmacologic Profiles, Efficacy, and Safety in Treatment of Shock.

(Feldman R, Stanton M, Chinn M, Grawey T, Weston B.) WMJ. 2020 Dec;119(4):240-247 PMID: 33428833 SCOPUS ID: 2-s2.0-85099890579 01/12/2021
National assessment of pharmacist awareness of loperamide abuse and ability to restrict sale if abuse is suspected.

(Feldman R, Everton E.) J Am Pharm Assoc (2003). 2020 Nov - Dec;60(6):868-873 PMID: 32641253 07/10/2020
Culprit or correlate? An application of the Bradford Hill criteria to Vitamin E acetate.

(Feldman R, Meiman J, Stanton M, Gummin DD.) Arch Toxicol. 2020 06;94(6):2249-2254 PMID: 32451600 SCOPUS ID: 2-s2.0-85085053459 05/27/2020
Involvement of pharmacist-reviewed urine cultures and sexually transmitted infections in the emergency department reduces time to antimicrobial optimization.

(Olson A, Feih J, Feldman R, Dang C, Stanton M.) Am J Health Syst Pharm. 2020 May 19;77(Supplement_2):S54-S58 PMID: 32426834 SCOPUS ID: 2-s2.0-85084786424 05/20/2020
Chapter: Smoke Inhalations and Toxic Exposures. In: PSAP 2020 Book 1 Critical and Urgent Care.

(Oltrogge Pape K, Feldman R..) . 01/01/2020
Medical outcomes of bromethalin rodenticide exposures reported to US poison centers after federal restriction of anticoagulants.

(Feldman R, Stanton M, Borys D, Kostic M, Gummin D.) Clin Toxicol (Phila). 2019 Nov;57(11):1109-1114 PMID: 30892957 SCOPUS ID: 2-s2.0-85063130949 03/21/2019
Feldman, R. Chapter 7. The use of drugs under pressure. in: Kindwall, E; Whelan, H. Hyperbaric Medicine Practice 4th ed. Flagstaff, AZ: Best Publishing Company; 2017, p. 131-159.

(.) . 08/06/2019
Feldman R, Daniels A. Elizabethkingia endovascular infection. Society of Infectious Disease Pharmacist newsletter.

(.) . 08/06/2019
Severe lead toxicity attributed to bullet fragments retained in soft tissue.

(Weiss D, Lee D, Feldman R, Smith KE.) BMJ Case Rep. 2017 Mar 08;2017 PMID: 28275014 PMCID: PMC5353372 03/10/2017
Treatment of Paecilomyces variotii pneumonia with posaconazole: case report and literature review.

(Feldman R, Cockerham L, Buchan BW, Lu Z, Huang AM.) Mycoses. 2016 Dec;59(12):746-750 PMID: 27401982 SCOPUS ID: 2-s2.0-84978191719 07/13/2016

I believe engaged and supported learners who understand how to apply their knowledge in the clinical realm will be prepared to succeed in the healthcare field. By investing in the students success and providing support for didactic learning, they can allow their professional goals to become the motivators of the learning process. This creates passionate healthcare professionals with both the tools and motivation to improve the system we work in

Ryan Feldman, PharmD, BCPS, DABAT

July 2019

Ryan Feldman, PharmD, BCPS, DABAT